One approach to quantitate RNA is the use of a known number of competitive internal standard molecules that are reverse-transcribed and subsequently co-amplified under the same reaction conditions as the target sequence (3) . This technique, called competitive reverse transcription polymerase chain reaction (cRT-PCR) has been applied to monitor the level of hepatitis C virus (HCV) RNA in patients' serum samples (2, 5) .
Quantitation of HCV RNA may have important implications for treatment strategies and clinical outcome (4) . However, synthesis of competitive internal standard is labor-intensive, requiring the use of plasmid vectors and deletion techniques (2, 5) .
We describe a simple method for quantitation of HCV RNA using an in vitro-synthesized, non-plasmid-generated HCV competitive internal standard.
As shown in Figure 1 , a 125-base single-stranded (ss)DNA fragment with T7 promoter that also contained sequences for HCV probe, sense and antisense primers was synthesized by a Model 391 PCR-Mate ™ DNA Synthesizer (PE Applied Biosystems, Foster City, CA, USA). The ssDNA was then amplified for 40 cycles in a DNA Thermal Cycler 480 (Perkin-Elmer, Norwalk, CT, USA) in a 0.5-mL Eppendorf ® Safe-Lock Microcentrifuge Tube (Brinkmann Instruments, Westbury, NY, USA), overlaid with 50 µ L of mineral oil with a set of primers: sense 5 ′ -AATTTAATACGACTCACTATAG-GGAACTG-3 ′ and antisense 5 ′ -CGA-GACCTCCCGGGGCACTCGCA-AGCACCC-3 ′ to generate a doublestranded DNA. The PCR amplification mixture (final volume 50 µ L) contained 5 µ L 10 ×PCR buffer (100 mM TrisHCl, pH 8.3, 500 mM KCl, 15 mM
Perkin-Elmer), 1 µ L each of sense and antisense primer (50 pmol/ µ L), 33 µ L distilled water and 30 pmol (2 µ L) of the 125-base ssDNA. The amplification profile was as follows: denaturation at 94°C for 1 min, annealing at 55°C for 1 min and extension at 72°C for 1.5 min. Following the PCR, 5 µ L of a 1:1000 dilution of the amplification product were subjected to two hours of in vitro transcription at 37°C using the Large Scale T7 Transcription Kit (Novagen, Madison, WI, USA) according to the manufacturer's protocol. This was followed by digestion of the template DNA with 5 U of RNase-free DNase I (Novagen) at 37°C for 1 h. The synthesized RNA was extracted once with 100 µ L of phenol/chloroform isoamyl alcohol (CIAA; 1:1; Amersham, Arlington Heights, IL, USA) and once with CIAA without phenol (Amersham). The extracted RNA was then precipitated in isopropanol, washed with 70% ethanol and resuspended in 100 µ L of nuclease-free water. The RNA was further purified by passing through a Quick Spin ™ G-50 Sephadex ® Column (Boehringer Mannheim, Indianapolis, IN, USA) according to the manufacturer's instructions, and the amount of RNA was estimated by reading the absorbance at 260 nm in a UV spectrometer (UV/VIS Lambda 2; Perkin-Elmer). The optical density was translated to mg/mL, from which the number of amplicons was deduced. The presence of synthesized RNA and complete degradation of template DNA were confirmed by the lack of PCR product before, and its presence after, RT-PCR.
Total nucleic acid was extracted from 100 µ L of serum sample from an HCV-positive patient using the IsoQuick ® Nucleic Acid Extraction Kit (ORCA Research, Bothell, WA, USA) according to the manufacturer's instructions. The extracted nucleic acid was then dissolved in 10 µ L of nuclease-free water, and 2 µ L of this were subjected to RT-PCR in the presence of increasing concentrations of competitor RNA molecules (10 2 -10 8 ). Briefly, cRT was performed in a 0.2-mL MicroAmp ® tube (GeneAmp ® PCR System 9600; Perkin-Elmer) containing: 4 µ L 25 mM MgCl 2 , 2 µ L 10 ×PCR buffer II (100 mM Tris-HCl, 500 mM KCl, pH 8. were then blotted onto a nylon membrane (Hoefer Pharmacia Biotech, San Francisco, CA, USA) and probed with an alkaline phosphatase-conjugated chemiluminescent probe (-56 to -96) 5 ′ -CTGCTAGCCGAGTAGTGT TGG-GTCGCGAAAGGCCT TGTGG-3 ′ (LIGHTSMITH™ II; Promega, Madison, WI, USA). The membrane was exposed to Kodak X-OMAT X-ray Film (Eastman Kodak, Rochester, NY, USA) at 37°C for 3 h, and relative intensity of the bands was determined and used to approximate the amount of viral RNA in the patient serum as shown in Figure  2 (bottom).
In conclusion, the use of in vitrosynthesized competitor RNA in RT-PCR appears to be a feasible way to quantitate HCV RNA in patient sera, avoiding cumbersome cloning techniques. Furthermore, this method could be used to determine the presence of PCR inhibitors because any inhibitor influencing the efficacy of target amplification will have similar effect on the amplification of competitor RNA.
Combining Multiplex and Touchdown PCR to Screen Murine Microsatellite Polymorphisms
BioTechniques 23:36-44 (July 1997) We describe an improved, nonradioactive method for simultaneous amplification of up to three murine microsatellites. This strategy, which we term multiplex-touchdown polymerase chain reaction (PCR), is done in a single PCR tube with three pairs of primers. In general, a number of differently sized bands (Figure 1, lanes 1 and 2) are usually obtained from PCR amplification of microsatellites. These spurious bands are probably caused by primer mispairing and/or the template switching by TaqDNA polymerase (5,11), and they can seriously complicate genotypic interpretation. To overcome this problem, we first established rigorous conditions for touchdown PCR using a hot-start step (2) (96°C for 3 min). Our protocol was modified from those reported previously (3,7,9); however, we optimized the amplification conditions so that only DNA bands of the expected size were present as the single major bands observed on the non-denaturing polyacrylamide gel (Figure 1, lanes 3 and 4) . An initial annealing temperature of 65°C gave good results for all 55 microsatellite markers listed in Table 1 . This temperature is 5°o r 10°C higher than the targeted annealing temperature calculated from the melting temperature for each primer pair [2°C (A+T) plus 4°C (G+C)] 
